Paulson & Co. Inc. bought $15.6M of Bausch Health Companies (BHC)
Executed Nov 25 2025, disclosed Nov 28 2025, 3 days later.
Over the 21 trading sessions from the disclosed entry session (Nov 28 2025), the stock returned +13.9% (delay-adjusted); from the execution session (Nov 25 2025), +17.1%. Derived: entry at the session's open, exit at the close 20 sessions later.
Paulson & Co. Inc. (Other) filed 7 Form 4 reports as a reporting entity in the trailing twelve months (6 purchases, 1 sale), most often in International Tower Hill Mines Ltd. (THM). Across 6 priced purchase filings, the average 21-session return was +5.2% from execution and +8.2% from disclosure (delay-adjusted; derived). The largest single filing was $146.8M of AAMI (1,900,000 sh × $77.25, as filed), executed Jun 17.
Healthcare · Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→